Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. It offers medical and surgical equipment, pharmaceutical products, back office products, orthopedic products, and instruments, such as cotton balls, exam tables, diagnostic lights, tongue depressors, ECG equipment and supplies, spirometry equipment, rapid lab testing equipment and supplies, disposable items, and more. The Company’s customers include physicians, obstetricians and gynecologists, pediatricians, surgeons, vocational schools, correctional complexes, state and Government agencies, occupational and industrial healthcare facilities, and other specialty practices in the United States.

Employee Rating

3.2More
TypePublic
HQWixom, US
Founded1995
Size (employees)300 (est)
Websiterockwellmed.com
Rockwell Medical was founded in 1995 and is headquartered in Wixom, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Rockwell Medical

Robert Chioini

Robert Chioini

Founder, Chairman, CEO & President
Thomas Klema

Thomas Klema

Vp & CFO
Show more

Rockwell Medical Office Locations

Rockwell Medical has an office in Wixom
Wixom, (HQ)
30142 Wixom Road
Show all (1)
Report incorrect company information

Rockwell Medical Financials and Metrics

Rockwell Medical Revenue

Embed Graph
View revenue for all periods
Rockwell Medical's revenue was reported to be $57.30 m in FY, 2017
USD

Revenue (Q3, 2018)

16.7m

Gross profit (Q3, 2018)

2.0m

Gross profit margin (Q3, 2018), %

11.8%

Net income (Q3, 2018)

28.9k

EBIT (Q3, 2018)

(5.0m)

Market capitalization (4-Dec-2018)

173.8m

Closing stock price (4-Dec-2018)

3.1

Cash (30-Sep-2018)

4.3m
Rockwell Medical's current market capitalization is $173.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

52.4m54.2m55.4m53.3m57.3m

Revenue growth, %

3%2%(4%)

Cost of goods sold

45.7m11.9m46.4m46.5m53.6m

Gross profit

6.7m42.3m8.9m6.8m3.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

13.1m13.0m13.0m13.7m13.9m13.0m14.4m13.6m13.5m12.8m14.6m13.2m14.6m14.9m14.9m16.7m

Cost of goods sold

11.5m11.3m11.0m11.5m11.6m10.9mwdxefcqufszuzezftuxetqsqxt11.9m11.9m12.0m11.2m12.2m11.7m13.6m15.7m18.9m14.7m

Gross profit

1.6m1.7m2.0m2.3m2.3m2.1m2.5m1.7m1.5m1.6m2.4m1.5m1.1m(720.5k)(4.0m)2.0m

Gross profit Margin, %

12%13%15%17%17%16%17%12%11%12%16%11%7%(5%)(27%)12%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

11.9m65.8m31.2m17.2m8.4m

Accounts Receivable

Inventories

2.8m3.9m7.9m12.1m7.6m

Current Assets

31.9m94.7m84.6m78.5m48.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

21.2m661.1k2.9m3.0m63.3m37.1m33.2m30.0m23.8m19.3m11.9m8.3m3.9m3.3m1.7m4.3m

Accounts Receivable

2.2m

Inventories

2.8m2.9m2.8m3.0m5.2m6.3m7.4m9.2m11.0m11.8m13.4m13.8m14.9m5.5m4.5m4.6m

Current Assets

38.9m22.3m21.7m19.9m94.0m88.4m87.9m85.8m84.0m79.8m74.8m63.8m61.2m41.2m35.5m32.1m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(8.3m)(21.3m)(5.8m)(19.8m)

Depreciation and Amortization

1.0m996.3k822.3k762.4k514.4k

Inventories

(150.0k)

Accounts Payable

(6.1m)(3.4m)1.9m(1.6m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(3.2m)(14.9m)(3.7m)(2.5m)(2.4m)(4.8m)(5.4m)(4.6m)(4.7m)(17.8m)(22.7m)

Depreciation and Amortization

752.4k257.8k506.5k767.4k207.9k408.3k608.2k200.1k396.0k583.5k130.2k259.1k384.8k129.1k281.3k467.0k

Inventories

15.5k(2.4m)59.4k1.3m3.7m

Accounts Payable

(7.7m)(3.6m)(2.4m)425.3k981.0k(598.4k)(1.9m)(2.0m)(1.7m)(209.2k)
USDY, 2018

Financial Leverage

3 x
Show all financial metrics
Report incorrect company information

Rockwell Medical Online and Social Media Presence

Embed Graph
Report incorrect company information

Rockwell Medical News and Updates

Rockwell Medical, Inc. Appoints New Vice President, Marketing

WIXOM, Mich., Dec. 3, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today announced that Charlie Shiner has been appointed Vice President, Marketing, effective immediately. Mr. Shiner will report to Stuart Paul, President & Chief...

Rockwell Medical, Inc. Reports Third Quarter 2018 Financial Results

WIXOM, Mich., Nov. 9, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company") today reported financial results for the third quarter ended September 30, 2018, and highlighted recent and upcoming corporate milestones. Business Updates: CMS Rule Clarifies U.S. Commercial...

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Rockwell Medical, Inc. (RMTI) and September 25 Lead Plaintiff Deadline

NEW YORK, Sept. 19, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell" or the...

September 25th Deadline Alert: Bernstein Liebhard LLP Announces That A New Securities Class Action Lawsuit Expanding The Relevant Class Period Has Been Filed Against Rockwell Medical, Inc. - RMTI

NEW YORK, Sept. 6, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a new securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Rockwell Medical, Inc. ("Rockwell" or the...

Rockwell Medical Appoints Jim McCarthy as New SVP, Business and Corporate Development

WIXOM, Mich., Sept. 4, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today announced that Jim McCarthy, has been appointed Senior Vice President, Corporate and Business Development, effective September 4, 2018. In this newly-formed role,...

RMTI LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Rockwell Medical, Inc. - RMTI

NEW YORK, Aug. 18, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rockwell Medical, Inc. (NASDAQ: RMTI) between March 16, 2018 and June 26, 2018, inclusive (the "Class...
Show more
Report incorrect company information

Rockwell Medical Company Life and Culture

Report incorrect company information

Rockwell Medical Frequently Asked Questions

  • When was Rockwell Medical founded?

    Rockwell Medical was founded in 1995.

  • Who are Rockwell Medical key executives?

    Rockwell Medical's key executives are Robert Chioini and Thomas Klema.

  • How many employees does Rockwell Medical have?

    Rockwell Medical has 300 employees.

  • What is Rockwell Medical revenue?

    Latest Rockwell Medical annual revenue is $57.3 m.

  • What is Rockwell Medical revenue per employee?

    Latest Rockwell Medical revenue per employee is $191 k.

  • Who are Rockwell Medical competitors?

    Competitors of Rockwell Medical include Nikkiso, Aerogen and Abbott.

  • Where is Rockwell Medical headquarters?

    Rockwell Medical headquarters is located at 30142 Wixom Road, Wixom.

  • Where are Rockwell Medical offices?

    Rockwell Medical has an office in Wixom.

  • How many offices does Rockwell Medical have?

    Rockwell Medical has 1 office.